Civica Rx, a non-profit venture including 22 hospitals in the Salt Lake City area, is looking to produce cheap generics to combat high drug prices and drug shortages, Vox reports.
The company, per the report, will focus on generics that are either in short supply or experiencing price increases. In response, Civica Rx would produce cheaper alternatives.
Northwestern University Kellogg School of Management’s Craig Garthwaite tells Vox the partnership “represents a realistic means of addressing the problem of small market generic pricing.”
A Food and Drug Administration database reveals 100-plus generic drugs are classified as being in short supply.
To read the full report on Vox, click here.